The Oncosearch | Oncotarget

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations Research Paper

Soo Yeon Hahn, Tae Hyuk Kim, Chang Seok Ki, Sun Wook Kim, Soohyun Ahn, Jung Hee Shin, Jae Hoon Chung

Published Nov 14, 2017 · Vol. 8, No. 65 · pp. 108946-108957

Unfavorable efficacy to ¹³¹I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb Research Paper

Na Zhang, Jun Liang, Yan-song Lin

Published Oct 26, 2017 · Vol. 8, No. 57 · pp. 97407-97415

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors Research Paper

Meenakshi Mehrotra, Rajesh R. Singh, Sanam Loghavi, Dzifa Yawa Duose, Bedia A. Barkoh, Carmen Behrens, Keyur P. Patel, Mark J. Routbort, Scott Kopetz, Russell R. Broaddus, L. Jeffrey Medeiros, Ignacio I. Wistuba, Rajyalakshmi Luthra

Published Oct 24, 2017 · Vol. 9, No. 12 · pp. 10259-10271

Prognostic factors for histiocytic and dendritic cell neoplasms Research Paper

Joji Shimono, Hiroaki Miyoshi, Fumiko Arakawa, Kensaku Sato, Takuya Furuta, Reiji Muto, Eriko Yanagida, Yuya Sasaki, Daisuke Kurita, Keisuke Kawamoto, Koji Nagafuji, Koichi Ohshima

Published Oct 19, 2017 · Vol. 8, No. 58 · pp. 98723-98732

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism Research Paper

Muhammad Kashif, Claes Andersson, Sharmineh Mansoori, Rolf Larsson, Peter Nygren, Mats G. Gustafsson

Published Oct 19, 2017 · Vol. 8, No. 61 · pp. 103952-103967

PIK3CA^H1047R-induced paradoxical ERK activation results in resistance to BRAF^V600E specific inhibitors in BRAF^V600E PIK3CA^H1047R double mutant thyroid tumors Research Paper

Matthias A. Roelli, DorothÃ©e Ruffieux-DaidiÃ©, Amandine Stooss, Oussama ElMokh, Wayne A. Phillips, Matthias S. Dettmer, Roch-Philippe Charles

Published Oct 11, 2017 · Vol. 8, No. 61 · pp. 103207-103222

Clinicopathological and genetic characteristics of pulmonary large cell carcinoma under 2015 WHO classification: a pilot study Clinical Research Papers

Renwang Liu, Jinghao Liu, Tao Shi, Xiongfei Li, Dian Ren, Gang Chen, Ying Li, Hongyu Liu, Song Xu, Jun Chen

Published Oct 11, 2017 · Vol. 8, No. 59 · pp. 100754-100763

Tumor-suppressive function of UNC5D in papillary thyroid cancer Research Paper

Man-Man Zhang, Feng Sun, Bing Cui, Le-Le Zhang, Ya Fang, Yan Li, Rui-Jia Zhang, Xiao-Ping Ye, Yu-Ru Ma, Bing Han, Huai-Dong Song

Published Oct 10, 2017 · Vol. 8, No. 56 · pp. 96126-96138

Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine Research Paper

Helei Hou, Dong Liu, Chuantao Zhang, Yanxia Jiang, Guifang Lu, Na Zhou, Xiaonan Yan, Xiaoping Zhang, Zhuokun Li, Hongmei Zhu, Zhaoyang Qian, Xiaochun Zhang

Published Sep 27, 2017 · Vol. 8, No. 62 · pp. 105072-105080

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma Research Paper

Joshua Jiawei Zhou, Yuanshen Huang, Xue Zhang, Yabin Cheng, Liren Tang, Xiaodong Ma

Published Sep 27, 2017 · Vol. 8, No. 62 · pp. 105081-105092

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study Clinical Research Papers

Yousef Zakharia, Varun Monga, Umang Swami, Aaron D. Bossler, Michele Freesmeier, Melanie Frees, Mirza Khan, Noah Frydenlund, Rithu Srikantha, Marion Vanneste, Michael Henry, Mohammed Milhem

Published Sep 26, 2017 · Vol. 8, No. 51 · pp. 89182-89193

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF^V600E Priority Research Paper

Zeus A. Antonello, Nancy Hsu, Manoj Bhasin, Giovanni Roti, Mukta Joshi, Paul Van Hummelen, Emily Ye, Agnes S. Lo, S. Ananth Karumanchi, Christine R. Bryke, Carmelo Nucera

Published Sep 24, 2017 · Vol. 8, No. 49 · pp. 84743-84760

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers Research Paper

Mohamed E. Salem, Benjamin A. Weinberg, Joanne Xiu, Wafik S. El-Deiry, Jimmy J. Hwang, Zoran Gatalica, Philip A. Philip, Anthony F. Shields, Heinz-Josef Lenz, John L. Marshall

Published Sep 21, 2017 · Vol. 8, No. 49 · pp. 86356-86368

Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis Meta-Analysis

Ling Peng, Yina Wang, Yun Hong, Xianghua Ye, Peng Shi, Junyan Zhang, Qiong Zhao

Published Sep 19, 2017 · Vol. 8, No. 47 · pp. 83280-83291

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation Research Paper

Parisa Momtaz, James J. Harding, Charlotte Ariyan, Daniel G. Coit, Taha Merghoub, Billel Gasmi, Daoqi You, Agnes Viale, Katherine S. Panageas, Aliaksandra Samoila, Michael A. Postow, Jedd D. Wolchok, Paul B. Chapman

Published Sep 16, 2017 · Vol. 8, No. 62 · pp. 105000-105010

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways Priority Research Paper

Payal Jain, Amanda Silva, Harry J. Han, Shih-Shan Lang, Yuankun Zhu, Katie Boucher, Tiffany E. Smith, Aesha Vakil, Patrick Diviney, Namrata Choudhari, Pichai Raman, Christine M. Busch, Tim Delaney, Xiaodong Yang, Aleksandra K. Olow, Sabine Mueller, Daphne Haas-Kogan, Elizabeth Fox, Phillip B. Storm, Adam C. Resnick, Angela J. Waanders

Published Sep 15, 2017 · Vol. 8, No. 49 · pp. 84697-84713

Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice Research Paper

Martin Faehling, Birgit Schwenk, Sebastian Kramberg, Robert Eckert, Anna-Lena Volckmar, Albrecht Stenzinger, JÃ¶rn StrÃ¤ter

Published Sep 13, 2017 · Vol. 8, No. 44 · pp. 77897-77914

Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma Research Paper

Mari Kogiso, Lin Qi, Holly Lindsay, Yulun Huang, Xiumei Zhao, Zhigang Liu, Frank K. Braun, Yuchen Du, Huiyuan Zhang, Goeun Bae, Sibo Zhao, Sarah G. Injac, Mary Sobieski, David Brunell, Vidya Mehta, Diep Tran, Jeffrey Murray, Patricia A. Baxter, Xiao-Jun Yuan, Jack M. Su, Adekunle Adesina, Laszlo Perlaky, Murali Chintagumpala, D. Williams Parsons, Ching C. Lau, Clifford C. Stephan, Xinyan Lu, Xiao-Nan Li

Published Sep 8, 2017 · Vol. 8, No. 50 · pp. 87455-87471

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations Research Paper

Anika Bongaarts, Krinio Giannikou, Roy J. Reinten, Jasper J. Anink, James D. Mills, Floor E. Jansen, Wim G.M. Spliet, Willfred F.A. den Dunnen, Roland Coras, Ingmar BlÃ¼mcke, Werner Paulus, Theresa Scholl, Martha Feucht, Katarzyna Kotulska, Sergiusz Jozwiak, Anna Maria Buccoliero, Chiara Caporalini, Flavio Giordano, Lorenzo Genitori, Figen SÃ¶ylemezoÄŸlu, JosÃ© Pimentel, Mark Nellist, Antoinette Y.N. Schouten-van Meeteren, Anwesha Nag, Angelika MÃ¼hlebner, David J. Kwiatkowski, Eleonora Aronica

Published Sep 8, 2017 · Vol. 8, No. 56 · pp. 95516-95529

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma Research Paper

Monika Szymonek, Artur Kowalik, Janusz KopczyÅ„ski, Danuta GÄ…sior-Perczak, Iwona PaÅ‚yga, Agnieszka Walczyk, Klaudia Gadawska-Juszczyk, Agnieszka PÅ‚usa, Ryszard MÄ™Å¼yk, Magdalena Chrapek, StanisÅ‚aw GÃ³ÅºdÅº, Aldona Kowalska

Published Aug 24, 2017 · Vol. 8, No. 43 · pp. 74897-74909

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations Research Paper

Unfavorable efficacy to ¹³¹I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb Research Paper

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors Research Paper

Prognostic factors for histiocytic and dendritic cell neoplasms Research Paper

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism Research Paper

PIK3CA^H1047R-induced paradoxical ERK activation results in resistance to BRAF^V600E specific inhibitors in BRAF^V600E PIK3CA^H1047R double mutant thyroid tumors Research Paper

Clinicopathological and genetic characteristics of pulmonary large cell carcinoma under 2015 WHO classification: a pilot study Clinical Research Papers

Tumor-suppressive function of UNC5D in papillary thyroid cancer Research Paper

Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine Research Paper

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma Research Paper

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study Clinical Research Papers

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF^V600E Priority Research Paper

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers Research Paper

Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis Meta-Analysis

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation Research Paper

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways Priority Research Paper

Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice Research Paper

Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma Research Paper

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations Research Paper

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations Research Paper

Unfavorable efficacy to 131I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb Research Paper

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors Research Paper

Prognostic factors for histiocytic and dendritic cell neoplasms Research Paper

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism Research Paper

PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors Research Paper

Clinicopathological and genetic characteristics of pulmonary large cell carcinoma under 2015 WHO classification: a pilot study Clinical Research Papers

Tumor-suppressive function of UNC5D in papillary thyroid cancer Research Paper

Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine Research Paper

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma Research Paper

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study Clinical Research Papers

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E Priority Research Paper

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers Research Paper

Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis Meta-Analysis

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation Research Paper

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways Priority Research Paper

Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice Research Paper

Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma Research Paper

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations Research Paper

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma Research Paper

Unfavorable efficacy to ¹³¹I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb Research Paper

PIK3CA^H1047R-induced paradoxical ERK activation results in resistance to BRAF^V600E specific inhibitors in BRAF^V600E PIK3CA^H1047R double mutant thyroid tumors Research Paper

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF^V600E Priority Research Paper